Caninsulin® vet. 40 IU/ml, suspension for injection
Caninsulin® vet. 40 IU/ml, suspension for injection
Authorised
- Insulin porcine
Product identification
Medicine name:
Caninsulin® vet. 40 IU/ml, suspension for injection
Caninsulin vet. 40 IU/ml suspensija injekcijām suņiem un kaķiem
Active substance:
- Insulin porcine
Target species:
-
Dog
-
Cat
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Insulin porcine40.00/international unit(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QA10AC03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Latvia
Available in:
-
Latvia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Fixed combination application (Article 13b of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International GmbH
- Oriola Sweden AB
Responsible authority:
- Food And Veterinary Service
Authorisation number:
- V/MRP/13/0021
Date of authorisation status change:
Reference member state:
-
Sweden
Procedure number:
- SE/V/0119/001
Concerned member states:
-
Estonia
-
Finland
-
Latvia
-
Norway
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 23/01/2024
Latvian (PDF)
Published on: 27/09/2024
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 27/09/2024